GHK-Cu's Unique Regulatory Situation What makes GHK-Cu's regulatory story unique is its dual classification based on route of administration: What This Means Non-injectable GHK-Cu (topical creams, serums, etc.) was in Category 1 meaning it was under evaluation but generally available for compounding
These often improve as the body adjusts, but if symptoms worsen or persist, medical advice should be sought promptly
Access the Endocrinology Newsmakers Dashboard (Free Excel) Drugmakers work on triple agonist therapies to treat diabetes, obesity Several drugmakers are working on triple agonist therapies that target multiple receptors, such as GLP-1, GIP and glucagon (GCG)
Less food means less bulk moving through the intestines, which further slows transit time
Rather than simply changing what consumers buy, GLP-1s appear to be changing who behaves like the traditional high-return apparel shopper, the report said